Search Orphan Drug Designations and Approvals
-
| Generic Name: | N-(4-(4-Amino-7-cyano-1-methyl-3-(4-((4-methylpyrimidin-2-yl)oxy)phenyl)-1H-pyrrolo[3,2-c]pyridin-2-yl)-3-methylphenyl)methacrylamide |
|---|---|
| Date Designated: | 08/21/2024 |
| Orphan Designation: | treatment of cholangiocarcinoma (CCA) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
3H (Suzhou) Pharmaceuticals Co., Ltd. Building C4, No.999 Yinshan Lake Road Wuzhong District Suzhou 215124 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







